文献速递母胎医学

妊娠期附件病变的诊断影像学:系统综述

Diagnostic imaging of adnexal lesions in pregnancy: systematic review
RSS 订阅 · Ultrasound in Obstetrics and Gynecology · 2026-10-06

该系统综述纳入16项研究共1674例患者和1660个附件病变,描述妊娠期附件病变的影像特征并评估现有风险模型的效能。多数研究为回顾性、基于超声。IOTA两步策略及ADNEX模型单独应用显示高特异度和高阴性预测值,但妊娠期蜕膜化子宫内膜异位囊肿被误分类为恶性限制了效能。

要点

  • 妊娠期附件病变以良性为主,良性占93.1%,交界性卵巢肿瘤占3.4%,恶性占3.5%。
  • 交界性卵巢肿瘤较蜕膜化子宫内膜异位囊肿更大(中位数88.0 mm vs 48.1 mm)。
  • IOTA模型在妊娠期保持高阴性预测值,但蜕膜化子宫内膜异位囊肿可被误判为恶性。

核心结论

  • 超声可可靠评估妊娠期附件病变,交界性卵巢肿瘤与恶性病变形态与非妊娠妇女相当,IOTA模型保持高阴性预测值以排除恶性。

研究设计与样本

  • PROSPERO注册的系统综述,检索建库至2025年8月1日发表的研究,遵循PRISMA指南并使用Covidence软件。
  • 共筛选3349项研究,40项全文审阅,最终纳入16项研究,含1674例患者和1660个附件病变。
  • 多数纳入研究为回顾性、基于超声;因研究异质性未对模型效能进行Meta分析。

主要发现

  • 排除6项仅报告良性病变的研究后,93.1%(1284/1379)患者为良性病变,3.4%(47/1379)为交界性卵巢肿瘤,3.5%(48/1379)为恶性病变。
  • 排除仅报告子宫内膜异位囊肿的研究后,最常见良性附件病变为单纯囊肿39.0%(393/1007)、成熟囊性畸胎瘤24.2%(244/1007)和子宫内膜异位囊肿14.9%(150/1007)。
  • 交界性卵巢肿瘤较蜕膜化子宫内膜异位囊肿更大(中位数88.0 mm vs 48.1 mm),多房实性相对更常见(30.0% vs 22.4%)。
  • 多数蜕膜化子宫内膜异位囊肿(83.9%)有1至3个乳头状突起,而多数交界性卵巢肿瘤(66.7%)有超过3个乳头状突起。
  • 报告的子宫内膜异位囊肿中蜕膜化发生率为11.8–39.5%。

关键数值与推荐

  • IOTA两步策略及ADNEX模型单独应用显示高特异度(70.0–90.2%)和高阴性预测值(90.0–98.3%),但效能受蜕膜化子宫内膜异位囊肿误分类为恶性限制。

局限性

  • 因研究异质性未对模型效能进行Meta分析。
  • 多数纳入研究为回顾性、基于超声。
  • 诊断模型效能受蜕膜化子宫内膜异位囊肿误分类为恶性限制。
  • 未来研究应改进诊断工具以更好区分良性与含实性成分的恶性囊肿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Objective To describe the imaging features of adnexal lesions during pregnancy and assess the performance of current models for the risk assessment of such lesions. Methods This was a PROSPERO-registered systematic review including studies published from inception to 1 August 2025 and was performed as per Preferred Reporting Systems for Systematic Reviews and Meta-Analysis guidance using Covidence software. Studies were included if they utilized an objective or standardized assessment of imaging features (based on the International Ovarian Tumor Analysis (IOTA) terms and definitions, or predefined categorical variables), expert description or quantitative data (such as lesion measurements and number of papillary projections) to assess the risk of adnexal lesions during pregnancy. Standardized extraction of imaging features was performed and classification of outcomes was based on histology, resolution or expert impression. Diagnostic model performance was also extracted. Meta-analysis of model performance was not performed owing to study heterogeneity. Results Overall, 3349 studies were screened, of which 40 underwent full-text review and 16 were included in the systematic review, comprising 1674 patients and 1660 adnexal lesions. Most included studies were retrospective and ultrasound-based. Excluding six studies that exclusively reported benign lesions, 93.1% (1284/1379) of patients had benign lesions, 3.4% (47/1379) had borderline ovarian tumors (BOTs) and 3.5% (48/1379) had malignant lesions. Excluding studies reporting exclusively on endometrioma, the most common benign adnexal lesions were simple cysts (39.0% (393/1007)), mature cystic teratomas (24.2% (244/1007)) and endometriomas (14.9% (150/1007)). Malignant lesions were most often epithelial ovarian cancer or metastases. Both BOTs and malignant lesions retained imaging characteristics comparable with those observed in non-pregnant women. Decidualization was present in 11.8–39.5% of reported endometriomas. While decidualized endometriomas (DEs) and BOTs typically share characteristics, experts noted distinguishing morphological features and behaviors. BOTs were larger (median, 88.0 mm vs 48.1 mm), and although both were predominantly unilocular-solid lesions, BOTs were relatively more often multilocular-solid (30.0% vs 22.4%) compared with DEs. Both showed high vascularity, with most cases having a color score of 3. Most DEs (83.9%) had one to three papillary projections, whereas most BOTs (66.7%) had more than three papillary projections. Diagnostic models, such as the IOTA two-step strategy and the Assessment of Different NEoplasias in the adneXa model alone, showed high specificity (70.0-90.2%) and negative predictive value (90.0-98.3%), but performance was limited by misclassification of DEs as malignant. Conclusions Ultrasound can reliably assess adnexal lesions in pregnancy. DEs and BOTs can appear similar owing to their morphological overlap. Both BOTs and malignant lesions in pregnancy show morphology comparable with that in non-pregnant women, and IOTA models maintain a high negative predictive value for excluding malignancy in such cases. Future research should refine diagnostic tools to improve the differentiation of benign from malignant cysts with solid components. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound in Obstetrics and Gynecology,查看原文。版权归原作者所有。

引用

  1. Ultrasound in Obstetrics and Gynecology:Diagnostic imaging of adnexal lesions in pregnancy: systematic review

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。